-
摘要: [目的]观察D-二聚体测定在结肠癌中的临床意义。[方法]62例接受治疗的结肠癌患者为观察组,以同期体检的健康人群为对照组;观察2组患者D-二聚体阳性率,观察组中发生转移及未发生转移患者化疗前的D-二聚体测定结果比较、化疗前后D-二聚体变化与疗效之间的关系、临床分期与D-二聚体含量之间的关系。[结果]观察组D-二聚体检查阳性率为46.77%,对照组为0%,观察组患者D-二聚体检查阳性率明显高于对照组(P<0.05)。观察组中未发生转移、发生周围淋巴结转移、发生远处脏器转移患者D-二聚体含量分别为(0.23±0.09)mg/L、(1.51±1.45)mg/L、(2.23±1.29)mg/L,三者之间比较差异有统计学意义(P<0.05);结肠癌Ⅱ期、Ⅲ期、Ⅳ期D-二聚体含量分别为(0.27±0.08)mg/L、(1.16±0.36)mg/L、(2.01±0.82)mg/L,各分期D-二聚体含量比较差异有统计学意义(P<0.05)。观察组化疗后完全缓解+部分缓解患者D-二聚体变化值为(-0.43±0.21)mg/L,较治疗前显著性下降(P<0.05);病变稳定患者为(0.08±0.09)mg/L,与治疗前无明显改变(P>0.05);病变进展患者为(0.92±0.34)mg/L,较治疗前显著升高(P<0.05)。[结论]D-二聚体含量与结肠癌发病情况、是否发生转移及转移情况、疾病临床分期、预后等有着密切的联系,应灵活运用并掌握该项检查。Abstract: [Objective] To investigate the clinical significance of determination of D two dimer in colon cancer.[Methods] Sixty-two patients with colon cancer in our hospital were selected as the observation group,while the healthy people at the same period in the medical examination center were selected as the control. The positive rate of D two dimer in two groups,value of D two dimer in patients with colon cancer metastasis and without metastasis, patients before and after receiving chemotherapy was determined. Relationship between the D two dimer change and the symptoms’ improvement was analyzed. Relationship between clinical stage and D two dimer were investigated.[Results] The positive rate of D two dimer in the observation group was 46.77%,while it was 0% in the control group (P<0.05).The concentration of D two dimer in the patients with no metastasis,lymph node metastasis,distant organ metastasis were (0.23± 0.09) mg/L,(1.51± 1.45) mg/L,and (2.23± 1.29) mg/L,respectively(P<0.05),which indicated that the value of D two dimer aggravated with colorectal cancer metastasis.The concentration of D two dimer in stage II,III,IV of colon cancer was (0.27±0.08)mg/L,(1.16±0.36)mg/L,and(2.01±0.82)mg/L,respectively(P<0.05), which suggested the later colon cancer staging,the higher concentration of the two D dimer.After chemotherapy,the value of two D dimer in patients with colon cancer (CR+PR) decreased to(0.43±0.21)mg/L(P<0.05), and in SD patients,it decreased to (0.08±0.09)mg/L (P>0.05),in PD patients,it increased to (0.92±0.34)mg/L(P<0.05).[Conclusion] D two dimer shows close relationship with colon cancer incidence,metastasis,clinical staging and prognosis of diseases.
-
Key words:
- colon cancer /
- D two dimer /
- carcinoembryonic antigen
-
-
[1] 黄永坤.结肠癌的临床治疗进展[J].中外医学研究, 2012, 10 (31):150-151.
[2] 雷友才.结肠癌腹腔镜手术治疗进展[J].吉林医学, 2010, 31 (15):2294-2295.
[3] 闫华, 赵崇高, 江涛.恶性肿瘤患者血浆D-二聚体和纤维蛋白原水平的检测与分析[J].河南科技大学学报 (医学版), 2007, 25 (1):27-28.
[4] 郑鸿, 陶莉, 蔡芸芸, 等.消化道肿瘤化疗前后D-二聚体与疗效的研究[J].药品评价, 2012, 9 (12):31-33.
[5] 杨雪飞, 黄伶, 李勇, 等.消化系统恶性肿瘤患者血浆D-二聚体测定的临床意义[J].肿瘤学杂志, 2008, 14 (4):305-306.
[6] 王正东, 徐兴祥, 黄谦, 等.非小细胞肺癌患者化疗前后血浆D-二聚体测定的临床意义[J].医药论坛杂志, 2010, 31 (20):26-28.
[7] 王帆, 钟陆行.结肠癌术后辅助治疗研究进展[J].南昌大学学报, 2010, 50 (9):99-102.
[8] 邱梅婷.恶性肿瘤患者D-二聚体、纤维蛋白原及其降解产物检测的临床意义[J].海南医学, 2012, 33 (13):97-98.
[9] 杨艳丽, 胡淑玲, 任健康, 等.恶性肿瘤患者血浆D-二聚体检测的临床意义[J].临床输血与检验, 2009, 11 (2):164-166.
[10] 黄学梅, 喻垚, 王亚丽, 等.D-二聚体在恶性肿瘤中的研究进展[J].国际检验医学杂志, 2012, 33 (15):1850-1853.
-
计量
- 文章访问数: 46
- PDF下载数: 99
- 施引文献: 0